A targeted therapy that has shown its power in fighting ovarian cancer in women including those with BRCA1 and BRCA2
Continue reading »Home » Health Problems »
New efforts to curb high blood pressure in Asia
The reality of treating high blood pressure in the world’s most populated continent is trickier these days, experts say. After
Continue reading »Behavioral health workforce faces critical challenges in meeting population needs
The US mental health system faces considerable challenges in delivering behavioral healthcare to populations in need. In a special supplement
Continue reading »Early exposure to BPA alters cardiac rhythm and may influence adverse cardiovascular outcomes
More than 8 million pounds of bisphenol A (BPA) is produced each year and reaches 90 percent of the population
Continue reading »Researchers uncover up to 100 potential drug targets for cancer
Protein researchers from the Novo Nordisk Foundation Center for Protein Research at the University of Copenhagen have used mass spectrometry-based
Continue reading »Deadly cancers show early, detectable differences from benign tumors
Do metastatic cancer tumors “break bad” or are they “born bad”? This question is an essential mystery in cancer early
Continue reading »Move it and use it: Exergaming may help those at risk of Alzheimer’s or related dementias
Older adults with mild cognitive impairment (MCI), often a precursor to Alzheimer’s, showed significant improvement with certain complex thinking and
Continue reading »Elevated homocysteine identified as metabolic risk factor for neurodegenerative diseases
The amino acid homocysteine occurs naturally in the human body, generated as a byproduct of methionine metabolism. Genetic diseases or
Continue reading »Hypnosis transforms treatment for chronic pain
Researchers from UNSW Sydney and Neuroscience Research Australia (NeuRA), Universidade Cidade de São Paulo, Brazil and the University of Washington,
Continue reading »Fremanezumab linked to fewer monthly migraine days
(HealthDay)—For patients with episodic migraine, fremanezumab is associated with a reduction in the mean number of monthly migraine days, according
Continue reading »